PRESS RELEASE published on 12/09/2024 at 22:15, 1 year ago NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer Nanobiotix completes Phase 1 study of NBTXR3 in pancreatic cancer, showing promising outcomes & safety profile. FDA approves new trial. Full data to be shared in 2025 FDA Approval Pancreatic Cancer NANOBIOTIX NBTXR3 Phase 1 Study
BRIEF published on 11/25/2024 at 09:53, 1 year ago Franchissement de Seuil par Baillie Gifford chez Nanobiotix Capital Droits De Vote Franchissement De Seuil NANOBIOTIX Baillie Gifford
BRIEF published on 11/25/2024 at 09:53, 1 year ago Threshold Crossing by Baillie Gifford at Nanobiotix Voting Rights Capital Threshold Crossing NANOBIOTIX Baillie Gifford
PRESS RELEASE published on 11/25/2024 at 09:48, 1 year ago Franchissement de seuil Déclaration de franchissement de seuil par Baillie Gifford & Co. pour NANOBIOTIX le 19 novembre 2024 Franchissement De Seuil NANOBIOTIX Baillie Gifford & Co.
BRIEF published on 10/31/2024 at 08:35, 1 year 1 month ago NANOBIOTIX to Participate in Investor Conferences in November Innovation Investors Healthcare Conférences NANOBIOTIX
BRIEF published on 10/31/2024 at 08:35, 1 year 1 month ago NANOBIOTIX participera aux conférences investisseurs en novembre Innovation Conférences Investisseurs Soins De Santé NANOBIOTIX
PRESS RELEASE published on 10/31/2024 at 08:30, 1 year 1 month ago NANOBIOTIX to Participate in Multiple Investor Conferences in November Nanobiotix to participate in multiple investor conferences in November, including Guggenheim, Stifel, and Jefferies events to discuss innovative healthcare approaches Investor Conferences Healthcare Innovation NANOBIOTIX Nanoparticle-based Approaches Late-stage Biotechnology
BRIEF published on 10/11/2024 at 22:20, 1 year 2 months ago Voting Rights and Share Capital Update by Nanobiotix Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 10/11/2024 at 22:20, 1 year 2 months ago Mise à jour des droits de vote et du capital social par Nanobiotix Euronext Paris Capital Social Nasdaq Droit De Vote NANOBIOTIX
PRESS RELEASE published on 10/11/2024 at 22:15, 1 year 2 months ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital information. Find out more about the company's innovative therapeutic approaches Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
Published on 12/19/2025 at 03:15, 3 hours 21 minutes ago Tactical Resources Announces Receipt Of Final Order Approving Arrangement With Plum Acquisition Corp. III
Published on 12/19/2025 at 01:10, 5 hours 26 minutes ago Ostrom Climate Exits Existing UPRIIS ERPA Arrangements
Published on 12/19/2025 at 01:00, 5 hours 36 minutes ago Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited
Published on 12/19/2025 at 00:50, 5 hours 46 minutes ago High Resolution Gravity Survey Targets Challenger Repeats
Published on 12/19/2025 at 00:00, 6 hours 36 minutes ago LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
Published on 12/19/2025 at 05:46, 49 minutes ago Rieter: Update on the Completion of the Acquisition of Barmag Ad-hoc announcement pursuant to Art. 53 LR
Published on 12/19/2025 at 05:45, 50 minutes ago Ad hoc announcement pursuant to Art. 53 LR News Release
Published on 12/19/2025 at 03:50, 2 hours 45 minutes ago SG-based Startup Galatek Raises $30M Series A to Accelerate AI-powered Automation in Life Sciences and Semiconductor Manufacturing
Published on 12/19/2025 at 03:05, 3 hours 30 minutes ago The National Museum of Singapore honours the nation's 60th anniversary with two new experiences to introduce Singapore's evolving story
Published on 12/19/2025 at 02:20, 4 hours 15 minutes ago ZPMC Wins First-Ever Crane Project in the Democratic Republic of the Congo, Supporting African Deep-Sea Port Development
Published on 12/18/2025 at 18:30, 12 hours 6 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 18:30, 12 hours 6 minutes ago Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde
Published on 12/18/2025 at 17:45, 12 hours 51 minutes ago Cie du Bois Sauvage: Vernietiging eigen aandelen
Published on 12/18/2025 at 17:45, 12 hours 51 minutes ago Damartex réaffirme son éligibilité au PEA-PME
Published on 12/18/2025 at 17:45, 12 hours 51 minutes ago Cie du Bois Sauvage : Cancellation of own shares
